Announcements

Posted: 2022-01-13

TLCR Annual Report 2021

Welcome to the 2021 annual report for Translational Lung Cancer Research.

Posted: 2021-11-05

Translational Lung Cancer Research (TLCR) is now a member of Committee on Publication Ethics (COPE)

Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Translational Lung Cancer Research (TLCR) is among the list of COPE membership.

Posted: 2021-07-01

New Impact Factor for Translational Lung Cancer Research: 6.498

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has attained its latest impact factor update for the 2020 citation year: 6.498.

Posted: 2021-02-01

TLCR Annual Report 2020

Welcome to the 2020 annual report for Translational Lung Cancer Research.

Posted: 2020-12-03

Translational Lung Cancer Research to publish monthly beginning in January 2021

Since its initiation in 2012, Translational Lung Cancer Research (TLCR) has been developing at a speedy pace with increasing readership and citations. In order to better serve the needs of readers and authors who have submitted or who might be going to submit manuscripts for publication to the Journal, the TLCR will move from a bimonthly to a monthly publication schedule beginning in January 2021.

Posted: 2020-06-30

New Impact Factor for Translational Lung Cancer Research: 5.132

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has attained its latest impact factor update for the 2019 citation year: 5.132.

Posted: 2020-04-29

AME entered an official partnership with Publons to enhance wide-ranging recognition for reviewers

AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020.

Posted: 2020-03-16

Implementation of transparent peer review at Translational Lung Cancer Research

With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to implement a transparent peer review process as an option for all manuscripts submitted to TLCR from March 18, 2020.

Posted: 2020-02-20

TLCR Annual Report 2019

Posted: 2019-10-15

Application of the CARE Guideline as reporting standard in Translational Lung Cancer Research

Translational Lung Cancer Research welcomes case reports which are supposed to report new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in the fields of medicine.

Posted: 2019-06-21

The First Impact Factor for Translational Lung Cancer Research: 4.806

Posted: 2019-05-20

Congratulations to Prof. Heather A. Wakelee, Prof. Caicun Zhou and Prof. Raymond U. Osarogiagbon on becoming Nominees for the IASLC 2019 Board of Directors Election

Congratulations to Prof. Heather A. Wakelee, Prof. Caicun Zhou and Prof. Raymond U. Osarogiagbon on becoming Nominees
for the IASLC 2019 Board of Directors Election

Posted: 2019-04-30

Join us at the 27th European Conference on General Thoracic Surgery, 9 – 12 June 2019, Dublin, Ireland

Posted: 2019-01-26

TLCR Annual Report 2018

Posted: 2018-10-11

Translational Lung Cancer Research, the 7th AME Journal indexed in SCIE

Posted: 2018-05-10

Join us at the 26th ESTS Annual Meeting, 27-30 May 2018, Ljubljana, Slovenia!

Posted: 2018-01-30

TLCR Annual Report (2017)

Posted: 2018-01-16

The 6th Asian Single Port VATS Symposium 2018 in Philippines on March 23-24, 2018

Posted: 2017-12-06

Welcome to the 2017 Taiwan Society for Therapeutic Radiology and Oncology Conference: “Bring Insight into Impacts” and Both Sides across the Strait Forum

Posted: 2017-10-01